Latest Distributions News

Tungsten Mining NL’s review of historic drilling at Mt Mulgine confirms significant shallow gold mineralisation, reinforcing its integrated gold-tungsten development approach. The findings highlight near-surface gold potential to offset pre-strip costs and accelerate tungsten extraction.

Metro Performance Glass is set to strengthen its balance sheet and support its turnaround strategy through a $15 million to $24 million equity raise, with Amari Metals Australia poised to become the majority shareholder. This recapitalisation aims to reduce debt and improve operational focus amid challenging market conditions.

Renergen Limited confirms all conditions for its acquisition scheme with ASP Isotopes Inc. have been met or waived, while outlining a contentious cash settlement for Share Appreciation Rights holders.

AVITA Medical has filed its Q2 2025 Form 10-Q, reaffirming its leadership in acute wound care with its FDA-approved RECELL System and expanding international footprint.

Elanor Commercial Property Fund has received an unsolicited off-market takeover offer from the Lederer Group, prompting the formation of an Independent Board Committee to evaluate the proposal and advise securityholders.

The Supreme Court of New South Wales has approved the acquisition scheme for Donaco International by On Nut Road Limited, setting the stage for share suspension and final payment in August 2025.

360 Capital Mortgage REIT (ASX – TCF) reported a robust FY25 with a 38.4% increase in distributions and a 74.6% rise in operating profit, underpinned by a high-quality fixed-rate loan portfolio and successful capital raisings.

360 Capital Mortgage REIT (TCF) reported a robust FY25 with a 21.5% total unitholder return and significant capital raising activity that doubled its market capitalization.

360 Capital Mortgage REIT delivered a robust FY25 with a 74.6% jump in profit and a successful $13.6 million capital raise, while maintaining a stable net tangible asset value per unit.

Atomo Diagnostics has secured a US$410,000 order from Lumos Diagnostics for its Pascal test cassettes, following Lumos's exclusive six-year US distribution deal for the FebriDx test with PHASE Scientific.

AMP reported a 9.2% increase in underlying net profit after tax to $131 million for the first half of 2025, driven by robust cashflow growth and steady performances across its wealth and banking divisions. The company also declared a 2.0 cents per share interim dividend, maintaining disciplined cost control amid ongoing strategic investments.

AMP Limited has announced an ordinary dividend of AUD 0.02 per share for the six months ending June 2025, with a 20% franking credit, payable in late September.